A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease
Clinical trial NCT03105102 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03105102
- Sponsor
- AbbVie
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-09
- Primary completion
- 2029-02-01
- Enrollment
- 1336
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.